Development of a multivalent vaccine against human herpesviruses

dc.contributor.author	Baiken, Y.
dc.contributor.author	Mussabekova, A.
dc.contributor.author	Aituov, B.
dc.contributor.author	Kashikova, S.
dc.contributor.author	Bexeitov, Y.
dc.contributor.author	Alibek, K.
dc.date.accessioned	2015-10-28T08:39:10Z
dc.date.available	2015-10-28T08:39:10Z
dc.date.issued	2013
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/552
dc.description.abstract	Current work demonstrates use of modern in silico tools for predicting peptide-based vaccine candidates. Four out of twenty one showed good HSV-2 neutralization activity. Further investigation is needed to obtain effective anti-HSV protective vaccine candidates. Future directions of this work will be further optimization of epitope selection strategy and use of other search algorithms.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	Nazarbayev University	ru_RU
dc.subject	first research week	ru_RU
dc.subject	multivalent vaccine	ru_RU
dc.subject	human herpesvirus	ru_RU
dc.title	Development of a multivalent vaccine against human herpesviruses	ru_RU
dc.type	Abstract	ru_RU